Akinori Minato

Kitakyushu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma.

Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma.

Journal: Cancer diagnosis & prognosis

Published: May 11, 2026

Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade.

Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 22, 2026

Editorial Comment to "Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan".

Editorial Comment to "Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan".

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 27, 2026

CLINICAL OUTCOMES OF NEUROENDOCRINE CARCINOMA OF THE URINARY BLADDER

CLINICAL OUTCOMES OF NEUROENDOCRINE CARCINOMA OF THE URINARY BLADDER

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 21, 2026

Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical Chemotherapy.

Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical Chemotherapy.

Journal: Cancer diagnosis & prognosis

Published: October 11, 2025

Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study.

Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study.

Journal: International journal of clinical oncology

Published: October 02, 2025

Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy.

Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy.

Journal: JMA journal

Published: September 22, 2025

Editorial Comment to "Does Accessory Pudendal Artery Preservation Increase the Risk of Positive Surgical Margins in Robot-Assisted Radical Prostatectomy?"

Editorial Comment to "Does Accessory Pudendal Artery Preservation Increase the Risk of Positive Surgical Margins in Robot-Assisted Radical Prostatectomy?"

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: August 26, 2025

Multicenter Retrospective Analysis of Acute Scrotum in the Kyushu-Okinawa Region: Diagnostic Practices, Management Patterns, and Predictors of Testicular Salvage.

Multicenter Retrospective Analysis of Acute Scrotum in the Kyushu-Okinawa Region: Diagnostic Practices, Management Patterns, and Predictors of Testicular Salvage.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: August 21, 2025

Adjuvant Nivolumab Therapy for Upper Tract Urothelial Carcinoma: A Single-Institution Study.

Adjuvant Nivolumab Therapy for Upper Tract Urothelial Carcinoma: A Single-Institution Study.

Journal: Cureus

Published: August 11, 2025

Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models.

Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models.

Journal: Journal of kidney cancer and VHL

Published: June 25, 2025

Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.

Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.

Journal: In vivo (Athens, Greece)

Published: March 19, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026